Cyclopentane

Cyclopentane

SCHEMBL97373

C1CCCC1.CCC(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.83
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
TDP1 Q9NUW8 4/20 0.47
ALDH1A1 P00352 3/20 0.47
AKR1B1 P15121 1/20 0.40
LDHA P00338 1/20 0.40
SRR Q9GZT4 1/20 0.40
LMNA P02545 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
CYP2C19 P33261 1/20 0.39
PPARG P37231 6/20 0.38
PPARD Q03181 6/20 0.38
PPARA Q07869 6/20 0.38
HDAC11 Q96DB2 5/20 0.38
TSHR P16473 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL2585876 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL27344153 1.00
Propionic Acid SCHEMBL28008056 1.00
Propionic Acid SCHEMBL29094849 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL5062880 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclooctane SCHEMBL27748002 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL4093030 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclopentane SCHEMBL28987168 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL29144978 0.96 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL11710549 0.96 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5565 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3766496-B1 ANLOTINIB FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2026-02-25 EP claimed
US-20250367187-A1 QUINOLINE DERIVATIVE USED FOR TREATING SMALL CELL LUNG CANCER CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2025-12-04 US claimed
US-12472173-B2 Quinoline derivative and antibody soft tissue sarcoma combination therapy CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-11-18 US claimed
EP-3957631-B1 QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2025-09-10 EP claimed
CN-118281153-B Composite anode material and preparation method and application thereof 成都工业学院 2025-03-21 CN claimed
CN-114787161-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-02 CN claimed
CN-118281153-A Composite anode material and preparation method and application thereof 成都工业学院 2024-07-02 CN claimed
CN-117860740-A Pharmaceutical composition for treating or preventing viral hepatitis and application thereof 中以海德人工智能药物研发股份有限公司 2024-04-12 CN claimed
WO-2024012470-A1 USE OF ADAMANTANE NITRATE COMPOUND IN PREVENTION AND TREATMENT OF CYTOKINE STORM 广州喜鹊医药有限公司 2024-01-18 WO claimed
US-20230219979-A1 PYRAZOLO[1,5-a]PYRIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHENZHEN ZHONGGE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2023-07-13 US claimed
CN-101835765-A Alkylsulfonyl-substituted thiazolide compounds ROMARK LAB LC 2010-09-15 CN claimed
CN-101820762-A Pyrrolotriazine derivatives for treating cancer through inhibition of aurora kinase BAYER HEALTHCARE LLC 2010-09-01 CN claimed
CN-101633662-A Prasugrel pharmaceutical acid addition salt as well as preparation method and pharmaceutical application thereof JIE CHAO 2010-01-27 CN claimed
CN-101412690-A Medicinal acid addition salt of silodosin, and preparation and medicament use thereof JIE CHAO (CN) 2009-04-22 CN claimed
CN-101238099-A Salts of vildagliptin NOVARTIS AG (CH) 2008-08-06 CN claimed
CN-1679568-A Use of n-substituted-1,5-di deoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections SEARLE & CO (US) 2005-10-12 CN claimed
CN-1202824-C Use of N-substituted 1, 5-dideoxy-1, 5-imino-D-glucitol compounds for the treatment of hepatitis virus infections SEARLE & CO (US) 2005-05-25 CN claimed
WO-2005013694-A1 INSECT REPULSIVE ALLOMONES FIDELINE (FR) 2005-02-17 WO claimed
CN-1422156-A Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections PHARMACIA CORP (US) 2003-06-04 CN claimed
CN-1328457-A Use of N-substituted 1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections SEARLE & CO (US) 2001-12-26 CN claimed